Akebia Therapeutics
AKBA
#7121
Rank
C$0.57 B
Marketcap
$2.63
Share price
2.23%
Change (1 day)
66.57%
Change (1 year)

EPS for Akebia Therapeutics (AKBA)

EPS in 2023 (TTM): -$0.86

According to Akebia Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.92. In 2022 the company made an earnings per share (EPS) of -$0.73 an increase over its 2021 EPS that were of -$2.44.

EPS history for Akebia Therapeutics from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.8618.12%
2022-$0.73-70%
2021-$2.44-38.63%
2020-$3.9817.37%
2019-$3.392.79%
2018-$3.3031.2%
2017-$2.51-51.39%
2016-$5.1757.89%
2015-$3.27-94.83%
2014-$63.34589.75%
2013-$9.18

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$20.32-2,310.94%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.37-684.38%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$20.23-2,300.83%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.34 154.69%๐Ÿ‡บ๐Ÿ‡ธ USA